186 related articles for article (PubMed ID: 28431630)
1. Kynurenic acid and its analogue can alter the opioid receptor G-protein signaling after acute treatment via NMDA receptor in rat cortex and striatum.
Samavati R; Zádor F; Szűcs E; Tuka B; Martos D; Veres G; Gáspár R; Mándity IM; Fülöp F; Vécsei L; Benyhe S; Borsodi A
J Neurol Sci; 2017 May; 376():63-70. PubMed ID: 28431630
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of opioid receptor mediated G-protein activity after chronic administration of kynurenic acid and its derivative without direct binding to opioid receptors.
Zador F; Samavati R; Szlavicz E; Tuka B; Bojnik E; Fulop F; Toldi J; Vecsei L; Borsodi A
CNS Neurol Disord Drug Targets; 2014; 13(9):1520-9. PubMed ID: 25478797
[TBL] [Abstract][Full Text] [Related]
3. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
Foster AC; Kemp JA; Leeson PD; Grimwood S; Donald AE; Marshall GR; Priestley T; Smith JD; Carling RW
Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317
[TBL] [Abstract][Full Text] [Related]
4. Long-term systemic administration of kynurenic acid brain region specifically elevates the abundance of functional CB
Zádor F; Nagy-Grócz G; Dvorácskó S; Bohár Z; Cseh EK; Zádori D; Párdutz Á; Szűcs E; Tömböly C; Borsodi A; Benyhe S; Vécsei L
Neurochem Int; 2020 Sep; 138():104752. PubMed ID: 32445659
[TBL] [Abstract][Full Text] [Related]
5. Kynurenine 3-hydroxylase inhibition in rats: effects on extracellular kynurenic acid concentration and N-methyl-D-aspartate-induced depolarisation in the striatum.
Urenjak J; Obrenovitch TP
J Neurochem; 2000 Dec; 75(6):2427-33. PubMed ID: 11080194
[TBL] [Abstract][Full Text] [Related]
6. Dopamine receptor activation reveals a novel, kynurenate-sensitive component of striatal N-methyl-D-aspartate neurotoxicity.
Poeggeler B; Rassoulpour A; Wu HQ; Guidetti P; Roberts RC; Schwarcz R
Neuroscience; 2007 Aug; 148(1):188-97. PubMed ID: 17629627
[TBL] [Abstract][Full Text] [Related]
7. Kynurenic acid, by targeting α7 nicotinic acetylcholine receptors, modulates extracellular GABA levels in the rat striatum in vivo.
Beggiato S; Antonelli T; Tomasini MC; Tanganelli S; Fuxe K; Schwarcz R; Ferraro L
Eur J Neurosci; 2013 May; 37(9):1470-7. PubMed ID: 23442092
[TBL] [Abstract][Full Text] [Related]
8. Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid.
Luchowska E; Luchowski P; Paczek R; Ziembowicz A; Kocki T; Turski WA; Wielosz M; Lazarewicz J; Urbanska EM
J Neurosci Res; 2005 Feb; 79(3):375-82. PubMed ID: 15605380
[TBL] [Abstract][Full Text] [Related]
9. Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?
Wu HQ; Rassoulpour A; Schwarcz R
J Neural Transm (Vienna); 2007 Jan; 114(1):33-41. PubMed ID: 16932989
[TBL] [Abstract][Full Text] [Related]
10. Prolonged nicotine administration results in biphasic, brain-specific changes in kynurenate levels in the rat.
Rassoulpour A; Wu HQ; Albuquerque EX; Schwarcz R
Neuropsychopharmacology; 2005 Apr; 30(4):697-704. PubMed ID: 15496939
[TBL] [Abstract][Full Text] [Related]
11. Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys.
Ko MC; Lee H; Harrison C; Clark MJ; Song HF; Naughton NN; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2003 Jul; 306(1):179-86. PubMed ID: 12676881
[TBL] [Abstract][Full Text] [Related]
12. The peripheral antinociceptive effects of endomorphin-1 and kynurenic acid in the rat inflamed joint model.
Mecs L; Tuboly G; Nagy E; Benedek G; Horvath G
Anesth Analg; 2009 Oct; 109(4):1297-304. PubMed ID: 19762760
[TBL] [Abstract][Full Text] [Related]
13. Long-term exposure to nicotine markedly reduces kynurenic acid in rat brain--in vitro and ex vivo evidence.
Zielińska E; Kuc D; Zgrajka W; Turski WA; Dekundy A
Toxicol Appl Pharmacol; 2009 Oct; 240(2):174-9. PubMed ID: 19616570
[TBL] [Abstract][Full Text] [Related]
14. Tonic facilitation of glutamate release by glycine binding sites on presynaptic NR2B-containing NMDA autoreceptors in the rat visual cortex.
Li YH; Han TZ; Meng K
Neurosci Lett; 2008 Feb; 432(3):212-6. PubMed ID: 18248890
[TBL] [Abstract][Full Text] [Related]
15. Enhanced striatal opioid receptor-mediated G-protein activation in L-DOPA-treated dyskinetic monkeys.
Chen L; Togasaki DM; Langston JW; Di Monte DA; Quik M
Neuroscience; 2005; 132(2):409-20. PubMed ID: 15802193
[TBL] [Abstract][Full Text] [Related]
16. Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid.
Erhardt S; Engberg G
Acta Physiol Scand; 2002 May; 175(1):45-53. PubMed ID: 11982504
[TBL] [Abstract][Full Text] [Related]
17. Effects of reboxetine and sertraline treatments alone and in combination on the binding properties of cortical NMDA and beta1-adrenergic receptors in an animal model of depression.
Harkin A; Nally R; Kelly JP; Leonard BE
J Neural Transm (Vienna); 2000; 107(10):1213-27. PubMed ID: 11129111
[TBL] [Abstract][Full Text] [Related]
18. Kynurenic Acid Prevents Cytoskeletal Disorganization Induced by Quinolinic Acid in Mixed Cultures of Rat Striatum.
Pierozan P; Biasibetti-Brendler H; Schmitz F; Ferreira F; Pessoa-Pureur R; Wyse ATS
Mol Neurobiol; 2018 Jun; 55(6):5111-5124. PubMed ID: 28840509
[TBL] [Abstract][Full Text] [Related]
19. Glycine binding sites of presynaptic NMDA receptors may tonically regulate glutamate release in the rat visual cortex.
Li YH; Han TZ
J Neurophysiol; 2007 Jan; 97(1):817-23. PubMed ID: 17093111
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of exercise on brain opioid receptor binding and activation in rats.
Arida RM; Gomes da Silva S; de Almeida AA; Cavalheiro EA; Zavala-Tecuapetla C; Brand S; Rocha L
J Neurochem; 2015 Jan; 132(2):206-17. PubMed ID: 25330347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
